The incidence of adverse effects with Benicar (the US trade name for<unk>  medoxomil) is reported as similar to placebo; the only adverse effect that occurred in >1% of patients treated with it and more frequently than placebo was dizziness (3% vs 1%). Rarely,<unk>  can cause severe gastrointestinal issues. The symptoms, which include nausea, vomiting, diarrhea, weight loss, and electrolyte abnormalities, are common among those who have celiac disease. Recent studies suggested this form of sprue-like enteropathy could be caused by the inhibition of TGF-β, a polypeptide cytokine that maintains intestinal homeostasis. However, it is still unclear why this action was never observed with other ARBs. In studies of angiotensin II receptor antagonists such as<unk> , patients with unilateral or bilateral renal artery stenosis, increases in serum creatinine or blood urea nitrogen have been reported. There has been no long-term use of<unk>  medoxomil in patients with unilateral or bilateral renal artery stenosis, but similar results may be expected. The full prescribing information for Benicar notes as with all drugs that act directly on the renin-angiotensin system,<unk>  is contraindicated in pregnancy and can cause injury and even death to the developing fetus.
Olmesartan
Cyclothiazide
Chlorothiazide
Azilsartan
Losartan
Telmisartan
Valsartan
Irbesartan